{"version":"1.0","type":"link","title":"Responding to Payor Policy Changes That Impact Patients with Postparalytic Facial Palsy: Chemodenervation with Botulinum Toxin.","author_name":"Miller MQ 외","author_url":"https://prs-insight.online/author/Miller%20MQ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/55021","thumbnail_width":1200,"thumbnail_height":630}